Antibody recognizing folate receptors alpha and beta
US-2015343088-A1 · Dec 3, 2015 · US
Microcin and uses thereof
US9492500B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9492500-B2 |
| Application number | US-201314407975-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 14, 2013 |
| Priority date | Jun 15, 2012 |
| Publication date | Nov 15, 2016 |
| Grant date | Nov 15, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Microcin MccPDI and bacteria harboring the mcpM gene which encodes MccPDI, limit growth of and/or kill pathogenic bacteria such as pathogenic Escherichia coli ( E. coli ) and/or Shigella bacteria via proximity-dependent inhibition (PDl).
First claim
Opening claim text (preview).
We claim: 1. A method of killing or decreasing adverse effects of pathogenic Escherichia coli ( E. coli ) and/or Shigella bacteria, comprising identifying a surface or subject known to or suspected of contamination with said pathogenic E. coli and/or Shigella bacteria; and contacting said pathogenic E. coli and/or Shigella bacteria with microcin MccPDI having SEQ ID NO: 24 or a functional variant thereof, or an organism that produces MccPDI SEQ ID NO: 24 or a func…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- A61K38/164Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9492500B2 cover?
- Microcin MccPDI and bacteria harboring the mcpM gene which encodes MccPDI, limit growth of and/or kill pathogenic bacteria such as pathogenic Escherichia coli ( E. coli ) and/or Shigella bacteria via proximity-dependent inhibition (PDl).
- Who is the assignee on this patent?
- Univ Washington State
- What technology area does this patent fall under?
- Primary CPC classification A61K38/164. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).